$ARIA Recent Headlines Six stocks to watch 4:27 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 20, 2014 at 1:21 PM

$ARIA Recent Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com

Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit 12:05 p.m. Sept. 19, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 9/11/14: LULU, ARIA, TITN, RSG 9:58 a.m. Sept. 12, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ISIS ARIA ACAD ALNY 8:00 a.m. Sept. 12, 2014 - InvestorPlace.com
Biotech Stock Mailbag: Achillion, Ariad Revisited, Endocyte 8:55 a.m. Sept. 5, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – CLDX ARIA CNC ZMH 7:45 a.m. Sept. 4, 2014 - InvestorPlace.com
'Mad Money' Lightning Round: Yahoo! Is One of the Best Buys Around 6:00 a.m. Sept. 4, 2014 - TheStreet.com
Cramer's Lightning Round - Yahoo Is A Good Steward Of Capital (9/3/14) 5:40 a.m. Sept. 4, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: These Are 3 Stocks Cramer Trusts 8:17 p.m. Sept. 3, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – CYH ARIA THC LUX 8:15 a.m. Aug. 29, 2014 - InvestorPlace.com
Biotechs With Insider Buying 2:16 p.m. Aug. 22, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ARIA CELG LCI RDY 9:15 a.m. Aug. 20, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up: 8/19/14 3:36 a.m. Aug. 20, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – PTCT LGND WX BIIB 1:45 p.m. Aug. 15, 2014 - InvestorPlace.com
ARIAD Falls on Wider-than-Expected Loss, Revenues Miss - Analyst Blog 12:21 p.m. Aug. 11, 2014 - Zacks.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q2 2014 Results - Earnings Call Transcript 5:30 p.m. Aug. 6, 2014 - Seeking Alpha
Why Ariad Pharmaceuticals (ARIA) Stock Is Down Today 1:07 p.m. Aug. 6, 2014 - TheStreet.com
Ariad updates guidance after Q2 results 8:51 a.m. Aug. 6, 2014 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q2 2014 Results - Earnings Call Webcast 8:25 a.m. Aug. 6, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. Aug. 5, 2014 - Seeking Alpha
Will GW Pharmaceuticals (GWPH) Miss this Earnings Season? - Analyst Blog 4:45 p.m. Aug. 5, 2014 - Zacks.com

INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 12:41 p.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 1:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 11:34 p.m. Aug. 6, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel 7:36 a.m. Aug. 5, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 7:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 7:35 a.m. July 14, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:01 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:36 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rare Collectibles Highlight Morphy's Auction on Oct 4

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

GBI Bio's New CEO Jesse McCool to Propel Growth

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

USFCR Wins 2026 Award for Federal Contracting Services

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Liberty Hill: 50 Years of Grassroots Revolution

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Moore Law Investigates Aardvark Therapeutics' Risks

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Crystal Risotti: Leading IT Compliance in Healthcare

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Albertsons Welcomes Once Upon a Coconut Nationwide

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Red-Eye Flights Surge, Driven By Western U.S. Routes

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Insurance Bad Faith: Navigating California's Rigorous Laws

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...